Periodic Reporting for period 2 - DECIDER (Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance in high-grade serous ovarian cancer)

Epithelial ovarian cancer kills more than 40,000 women in Europe each year. High-grade serous ovarian cancer (HGSOC) is the most common and most difficult-to-treat subtype of this disease. Despite initially good response to platinum and taxane, the HGSOC tumours typically...